Dr. An HOFMAN – fysische geneeskunde en revalidatie financials
A multi-period view of the public annual-account figures reported for Dr. An HOFMAN – fysische geneeskunde en revalidatie, with comparable measures and links to available source documents.
Company overviewRegistry number
0874411349
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Dr. An HOFMAN – fysische geneeskunde en revalidatie
2025 versus 2024
- Operating line
- €502,168
- EBITDA
- €498,089
- Total assets
- €1,938,322
- Equity
- €1,847,213
-31.9%
-32%
+22.7%
+23.4%
EBITDA margin +99.2% · Equity ratio +95.3%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €502,168 | €498,089 | €1,938,322 | €1,847,213 | - |
| 202430 Jun 2024 | €737,253 | €732,343 | €1,579,539 | €1,497,182 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.